Operating Lease, Right-of-Use Asset of Cytek Biosciences, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Cytek Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
Cytek Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $11,158,000, a 10% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cytek Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$11,158,000	+$1,034,000	+10%	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	$16,387,000	+$7,059,000	+76%	30 Jun 2025	10-Q	06 Aug 2025	2025	Q2
Q1 2025	$9,869,000	-$80,000	-0.8%	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$10,168,000	-$685,000	-6.3%	31 Dec 2024	10-Q	05 Nov 2025	2025	Q3
Q3 2024	$10,124,000	-$1,579,000	-13%	30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q2 2024	$9,328,000	-$3,095,000	-25%	30 Jun 2024	10-Q	06 Aug 2024	2024	Q2
Q1 2024	$9,949,000	-$3,238,000	-25%	31 Mar 2024	10-Q	08 May 2024	2024	Q1
Q4 2023	$10,853,000	-$3,030,000	-22%	31 Dec 2023	10-K	28 Feb 2025	2024	FY
Q3 2023	$11,703,000	-$2,713,000	-19%	30 Sep 2023	10-Q	14 Nov 2023	2023	Q3
Q2 2023	$12,423,000	-$1,212,000	-8.9%	30 Jun 2023	10-Q	08 Aug 2023	2023	Q2
Q1 2023	$13,187,000	-$696,000	-5%	31 Mar 2023	10-Q	09 May 2023	2023	Q1
Q4 2022	$13,883,000	+$13,883,000		31 Dec 2022	10-K	13 Mar 2024	2023	FY
Q3 2022	$14,416,000			30 Sep 2022	10-Q	09 Nov 2022	2022	Q3
Q2 2022	$13,635,000			30 Jun 2022	10-Q	10 Aug 2022	2022	Q2
Q1 2022	$13,883,000			31 Mar 2022	10-Q	09 May 2023	2023	Q1
Q4 2021	$0			31 Dec 2021	10-K	01 Mar 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.